Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Actinium Pharmaceuticals Inc (NY: ATNM )

11.54 -0.02 (-0.17%)
Streaming Delayed Price Updated: 12:27 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 92,894
Open 11.43
Bid (Size) 11.43 (5)
Ask (Size) 11.54 (2)
Prev. Close 11.56
Today's Range 11.28 - 11.66
52wk Range 4.410 - 15.12
Shares Outstanding 21,331,314
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Actinium Pharmaceuticals’ Shares Stay Bullish Ahead Of Expected Topline Phase 3 Data Release In Q4 ($ATNM)
Via AB Newswire
Actinium Pharmaceuticals’ Shares Rally Ahead Of Topline Phase 3 Data Release; Update Expected By Year’s End ($ATNM)
Via AB Newswire

Performance

YTD
+15.17%
+15.17%
1 Month
+8.36%
+8.36%
3 Month
-14.77%
-14.77%
6 Month
+139.92%
+139.92%
1 Year
+113.31%
+113.31%

More News

Read More
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday
Via Benzinga
Actinium Shares Are Trading Higher After Positive Data From Acute Myeloid Leukemia Trial
Via Benzinga
With Upcoming Pivotal Data, Analyst Sees 145% Upside In Actinium
Via Benzinga
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
Via Benzinga
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
4 Analysts Have This to Say About Actinium Pharmaceuticals
Via Benzinga
Why Is Getty Images (GETY) Stock Up 33% Today?
Via InvestorPlace
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
Via Benzinga
PERF Stock Soars 21% on First Trading Day
Via InvestorPlace
Actinium (ATNM) Stock Pops on Positive Trial Results
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Actinium Pharmaceuticals’ Q4 Phase 3 Trial Updates Could Make Expected Milestones 2023 Catalysts ($ATNM)
Via AB Newswire
Actinium Pharmaceuticals’ Investor Update Puts Clinical Milestones And Potential Catalysts In The Crosshairs ($ATNM)
Via AB Newswire
Top Cheap Stocks: Trading Opportunities For Next Week
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022
Via Benzinga
Biotech Stocks News: What’s Going on With LIXT, PTE, QLGN and ATNM Stocks Today?
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
Via Benzinga
Benzinga's Daily Brief On Trending Tickers For April 12, 2022: Veru, Kohl's Corporation, BioCardia, And More
Via Benzinga
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
Via Benzinga
Why Actinium Pharmaceuticals Stock Is Surging
Via Benzinga
Actinium Pharmaceuticals Rally Takes Stock 62% Higher As Its Iomab-B Data Continues To Impress (NYSE AMERICAN: ATNM)
Via AB Newswire
Exposures Product Safety
Actinium Pharmaceuticals Rally Intact As Its Iomab-B Data Shows 100% Effectiveness In Targeted Patient Population (NYSE AMERICAN: ATNM)
Via AB Newswire
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.